When stopping denosumab and transitioning to PO bisphosphanate, do you wait for 6 months after the last denosumab injection to start PO bipshosphanate?  

It is only recommended to stop denosumab if the patient fractures on therapy, develops ONJ, has an AFF, or has an intolerable adverse event. If the patient has any of these (except for an intolerable adverse event), it is not recommended to switch to a bisphosphonate but rather to romosozumab for on...

Some background: In patients discontinuing denosumab without subsequent antiresorptive therapy, BMD rapidly reverts back to baseline with an elevation in vertebral fracture risk (with an enhanced risk of multiple vertebral fractures). Thus, sequential treatment regimens following denosumab...